TYRA: Tyra Biosciences, Inc.
Performance
TYRA +55.73%
Watchlist
Select an item
Summary
TYRA at a glance
TYRA returned +55.73% over the past year and -4.70% a year over five years. Its worst drop in that year was -53.24%, smaller than 19% of stocks on Redstone, and its Sharpe ratio of 0.94 beats 72% of stocks on Redstone. It pays no dividends.
Current Drawdown
-43.70%
Rolling Volatility
45.52%
Actions
Metrics
Risk Indicators
Alpha58.18%
Beta0.52x
Sharpe0.94
Sortino1.46
Omega1.20
Calmar1.05
Martin2.56
Profile
About TYRA
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.5B
- Listed
- Sep 2021
- Employees
- 87
- Headquarters
- Carlsbad, CA
- Website
- tyra.bio
Comparisons